Home - Products - Others - Other Targets - 4-Hydroxy-3-nitrophenylacetic acid

4-Hydroxy-3-nitrophenylacetic acid

CAS No. 10463-20-4

4-Hydroxy-3-nitrophenylacetic acid( —— )

Catalog No. M10226 CAS No. 10463-20-4

It is a small molecular drug, active to Ig heavy chain V-I region and Ig gamma-2 chain C region.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
50MG 43 In Stock
100MG 56 In Stock
200MG 79 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Hydroxy-3-nitrophenylacetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    It is a small molecular drug, active to Ig heavy chain V-I region and Ig gamma-2 chain C region.
  • Description
    It is a small molecular drug, active to Ig heavy chain V-I region and Ig gamma-2 chain C region.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Ig gamma-2 chain C region| Ig heavy chain V-I region
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10463-20-4
  • Formula Weight
    197.14
  • Molecular Formula
    C8H7NO5
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    OC(=O)CC1=CC(=C(O)C=C1)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Berman HM, et al. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
molnova catalog
related products
  • AI-10-47

    AI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).

  • 3,3-Di-O-methylellag...

    3,3'-Di-O-methylellagic acid 4'-glucoside is a natural product.

  • mTOR inhibitor 9a

    mTOR inhibitor 9a inhibited the growth of human LNCap cells with an ic50 of 80 nm. 1-methyl-3 -{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea may have antitumor activity.